OutcomesOutcome
Total nasal symptom score (TNSS)
1 finding from 1 compound ↓reported in points (total score)
What moved it
How to read these marks1 finding · 1 compound · 1 null · by evidence strength. No dose is advised.
Total nasal symptom score (TNSS)
Findings drawn, by strength
1finding · 1 compound
- Moderate1
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
Not pooled · no summary effect · point at a mark · Tab, then the arrow keys
Measured, no difference found1 finding
- N-hexadecanoylethanolamineMoved: no difference foundEvidence: ModeratePaper: PMID 380687972023
- Who
- Adults aged 21 to 77 years with seasonal allergic rhinitis, 108 randomised and 101 completed; whole-population comparison, reflective total nasal symptom score recorded online twice daily
- Dose studied
- Levagen+ (PEA) 350 mg daily, two 175 mg capsules each morning, against placebo of 175 mg maltodextrin per capsule
No significant difference was seen between the Levagen+ and placebo groups for the allergy symptoms scores (rTNSS) at baseline or throughout the 14 days of treatment.”
Quoted verbatim from The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial.RCT · 14 daysPermalink
No row matches these filters.
How it is measured
Total Nasal Symptom Score, the sum of participant-rated severity of the nasal symptoms of allergic rhinitis (blocked or obstructed nose, runny nose or secretion, itching nose, sneezing), each rated on a 4-point scale, self-reported. Whether the score was taken under natural allergen exposure, in an allergen exposure chamber or after nasal allergen provocation, the recall period, and the number of items summed are recorded with each finding.
Papers about it
As an endpoint1
Show the paperHide the paper
The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial.
Nutrients2023PMID 38068797Via: named in the paper, as read